» Articles » PMID: 36691046

CCL3 Secreted by Hepatocytes Promotes the Metastasis of Intrahepatic Cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (mA) Modification

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2023 Jan 23
PMID 36691046
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Intrahepatic cholangiocarcinoma (ICC) is a malignant disease characterized by onset occult, rapid progression, high relapse rate, and high mortality. However, data on how the tumor microenvironment (TME) regulates ICC metastasis at the transcriptomic level remains unclear. This study aimed to explore the mechanisms and interactions between hepatocytes and ICC cells.

Methods: We analyzed the interplay between ICC and liver microenvironment through cytokine antibody array analysis. Then we investigated the role of N6-methyladenosine (mA) modification and the downstream target in vitro, in vivo experiments, and in clinical specimens.

Results: Our study demonstrated that cytokine CCL3, which is secreted by hepatocytes, promotes tumor metastasis by regulating mA modification via vir-like mA methyltransferase associated (VIRMA) in ICC cells. Moreover, immunohistochemical analyses showed that VIRMA correlated with poor outcomes in ICC patients. Finally, we confirmed both in vitro and in vivo that CCL3 could activate VIRMA and its critical downstream target SIRT1, which fuels tumor metastasis in ICC.

Conclusions: In conclusion, our results enhanced our understanding of the interaction between hepatocytes and ICC cells, and revealed the molecular mechanism of the CCL3/VIRMA/SIRT1 pathway via mA-mediated regulation in ICC metastasis. These studies highlight potential targets for the diagnosis, treatment, and prognosis of ICC.

Citing Articles

m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy.

Liu F, Liu Q, Li X, Wang Y, Cao R, Zhang S Front Immunol. 2025; 16:1538658.

PMID: 40034695 PMC: 11873077. DOI: 10.3389/fimmu.2025.1538658.


Liver Metastasis in Cancer: Molecular Mechanisms and Management.

Xu W, Xu J, Liu J, Wang N, Zhou L, Guo J MedComm (2020). 2025; 6(3):e70119.

PMID: 40027151 PMC: 11868442. DOI: 10.1002/mco2.70119.


EBV-Induced LINC00944: A Driver of Oral Cancer Progression and Influencer of Macrophage Differentiation.

Srisathaporn S, Ekalaksananan T, Heawchaiyaphum C, Aromseree S, Maranon D, Altina N Cancers (Basel). 2025; 17(3).

PMID: 39941858 PMC: 11815735. DOI: 10.3390/cancers17030491.


N-acetyltransferase 10 affects the proliferation of intrahepatic cholangiocarcinoma and M2-type polarization of macrophages by regulating C-C motif chemokine ligand 2.

Cai T, Dai J, Lin Y, Bai Z, Li J, Meng W J Transl Med. 2024; 22(1):875.

PMID: 39350174 PMC: 11440763. DOI: 10.1186/s12967-024-05664-z.


Landscape of mA RNA methylation regulators in liver cancer and its therapeutic implications.

Zhao J, Li G, Lu X, Zhu L, Gao Q Front Pharmacol. 2024; 15:1376005.

PMID: 38545555 PMC: 10965734. DOI: 10.3389/fphar.2024.1376005.


References
1.
Razumilava N, Gores G . Cholangiocarcinoma. Lancet. 2014; 383(9935):2168-79. PMC: 4069226. DOI: 10.1016/S0140-6736(13)61903-0. View

2.
Meyer K, Jaffrey S . The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat Rev Mol Cell Biol. 2014; 15(5):313-26. PMC: 4393108. DOI: 10.1038/nrm3785. View

3.
Miranda-Goncalves V, Lobo J, Guimaraes-Teixeira C, Barros-Silva D, Guimaraes R, Cantante M . The component of the mA writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors. J Exp Clin Cancer Res. 2021; 40(1):268. PMC: 8390281. DOI: 10.1186/s13046-021-02072-9. View

4.
Ong A, Ramasamy T . Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming. Ageing Res Rev. 2018; 43:64-80. DOI: 10.1016/j.arr.2018.02.004. View

5.
Chang G, Leu J, Ma L, Xie K, Huang S . Methylation of RNA N-methyladenosine in modulation of cytokine responses and tumorigenesis. Cytokine. 2018; 118:35-41. DOI: 10.1016/j.cyto.2018.06.018. View